55 related articles for article (PubMed ID: 38613349)
21. Revising the WHO classification: female genital tract tumours.
Cree IA; White VA; Indave BI; Lokuhetty D
Histopathology; 2020 Jan; 76(1):151-156. PubMed ID: 31846528
[TBL] [Abstract][Full Text] [Related]
22. Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma.
Zhou JG; Zhao HT; Jin SH; Tian X; Ma H
Gynecol Oncol; 2019 Dec; 155(3):499-507. PubMed ID: 31662204
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic osteomalacia and metastatic breast cancer: a case report and review of the literature.
Savva C; Adhikaree J; Madhusudan S; Chokkalingam K
J Diabetes Metab Disord; 2019 Jun; 18(1):267-272. PubMed ID: 31275898
[TBL] [Abstract][Full Text] [Related]
24. Uterine sarcomas.
Mbatani N; Olawaiye AB; Prat J
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
[TBL] [Abstract][Full Text] [Related]
25. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.
Tsuyoshi H; Yoshida Y
Cancer Sci; 2018 Jun; 109(6):1743-1752. PubMed ID: 29660202
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions.
Aukes K; Forsman C; Brady NJ; Astleford K; Blixt N; Sachdev D; Jensen ED; Mansky KC; Schwertfeger KL
PLoS One; 2017; 12(10):e0185736. PubMed ID: 28968431
[TBL] [Abstract][Full Text] [Related]
27. Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma.
Gunther JR; Christensen EN; Allen PK; Ramondetta LM; Jhingran A; Fleming ND; Euscher ED; Lu KH; Eifel PJ; Klopp AH
Int J Gynecol Cancer; 2018 Jan; 28(1):114-121. PubMed ID: 28930812
[TBL] [Abstract][Full Text] [Related]
28. Uterine Sarcomas: The Latest Approaches for These Rare but Potentially Deadly Tumors.
Chern JY; Boyd LR; Blank SV
Oncology (Williston Park); 2017 Mar; 31(3):229-36. PubMed ID: 28299760
[TBL] [Abstract][Full Text] [Related]
29. Significance of lymph node metastasis on survival of women with uterine adenosarcoma.
Machida H; Nathenson MJ; Takiuchi T; Adams CL; Garcia-Sayre J; Matsuo K
Gynecol Oncol; 2017 Mar; 144(3):524-530. PubMed ID: 28109626
[TBL] [Abstract][Full Text] [Related]
30. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
[TBL] [Abstract][Full Text] [Related]
31. Uterine Sarcoma: Analysis of 13,089 Cases Based on Surveillance, Epidemiology, and End Results Database.
Hosh M; Antar S; Nazzal A; Warda M; Gibreel A; Refky B
Int J Gynecol Cancer; 2016 Jul; 26(6):1098-104. PubMed ID: 27177280
[TBL] [Abstract][Full Text] [Related]
32. Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma.
Matsuo K; Takazawa Y; Ross MS; Elishaev E; Podzielinski I; Yunokawa M; Sheridan TB; Bush SH; Klobocista MM; Blake EA; Takano T; Matsuzaki S; Baba T; Satoh S; Shida M; Nishikawa T; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Fujiwara K; Hazama Y; Kadogami D; Moffitt MN; Takeuchi S; Nishimura M; Iwasaki K; Ushioda N; Johnson MS; Yoshida M; Hakam A; Li SW; Richmond AM; Machida H; Mhawech-Fauceglia P; Ueda Y; Yoshino K; Yamaguchi K; Oishi T; Kajiwara H; Hasegawa K; Yasuda M; Kawana K; Suda K; Miyake TM; Moriya T; Yuba Y; Morgan T; Fukagawa T; Wakatsuki A; Sugiyama T; Pejovic T; Nagano T; Shimoya K; Andoh M; Shiki Y; Enomoto T; Sasaki T; Fujiwara K; Mikami M; Shimada M; Konishi I; Kimura T; Post MD; Shahzad MM; Im DD; Yoshida H; Omatsu K; Ueland FR; Kelley JL; Karabakhtsian RG; Roman LD
Ann Oncol; 2016 Jul; 27(7):1257-66. PubMed ID: 27052653
[TBL] [Abstract][Full Text] [Related]
33. The prognosis factor of adjuvant radiation therapy after surgery in uterine sarcomas.
Hou HL; Meng MB; Chen XL; Zhao LJ; Zhu L; Zhang BL; Wang P
Onco Targets Ther; 2015; 8():2339-44. PubMed ID: 26357482
[TBL] [Abstract][Full Text] [Related]
34. Cellular mesenchymal tumors of the uterus: a review emphasizing recent observations.
Oliva E
Int J Gynecol Pathol; 2014 Jul; 33(4):374-84. PubMed ID: 24901397
[TBL] [Abstract][Full Text] [Related]
35. Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome.
Meng QH; Xu E; Hildebrandt MA; Liang D; Lu K; Ye Y; Wagar EA; Wu X
Clin Chem; 2014 Jan; 60(1):222-32. PubMed ID: 24146310
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.
Galaal K; van der Heijden E; Godfrey K; Naik R; Kucukmetin A; Bryant A; Das N; Lopes AD
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006812. PubMed ID: 23450572
[TBL] [Abstract][Full Text] [Related]
37. FIGO staging for uterine sarcomas.
Prat J
Int J Gynaecol Obstet; 2009 Mar; 104(3):177-8. PubMed ID: 19135669
[No Abstract] [Full Text] [Related]
38. Elevated fibroblast growth factor 23 in women with malignant ovarian tumors.
Tebben PJ; Kalli KR; Cliby WA; Hartmann LC; Grande JP; Singh RJ; Kumar R
Mayo Clin Proc; 2005 Jun; 80(6):745-51. PubMed ID: 15948297
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain.
Yamashita T; Yoshioka M; Itoh N
Biochem Biophys Res Commun; 2000 Oct; 277(2):494-8. PubMed ID: 11032749
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study.
Major FJ; Blessing JA; Silverberg SG; Morrow CP; Creasman WT; Currie JL; Yordan E; Brady MF
Cancer; 1993 Feb; 71(4 Suppl):1702-9. PubMed ID: 8381710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
